Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07223398 · ClinicalTrials.gov registry record · NA
Shared Decision Making to Treat Or Prevent (STOP) HIV in Justice Populations (R33)
A NA study of Substance Use Disorders, sponsored by Yale University.
- Recruiting
- Registry status
- NA
- Development phase
- 400
- Enrollment target
- 4
- Study locations
NCT07223398 is a NA study of Substance Use Disorders that is actively recruiting participants, run by Yale University. The registered enrollment target is 400 participants, below the 496-participant average among 93 other Substance Use Disorders trials with a reported enrollment target (19% lower). The trial reports 4 study locations across 3 states.
The verdict
NCT07223398, a NA study of Substance Use Disorders, is actively recruiting participants, sponsored by Yale University.
- RECRUITING
- Registry status
- NA
- Development phase
- 400 participants
- Enrollment target
- 4
- Study locations
Study Summary
This study seeks to compare the effectiveness of two Patient Navigation models of care to evaluate the proportion who initiate PrEP/ART and substance use/substance use disorder (SU/SUD) treatment. A standardized Patient Navigation (PN) arm will be compared with a shared decision-making model in the form of Patient Choice (PC) through the offer of a menu of existing community-based health service delivery options. This design will offer providers, correctional and public health authorities, payers and policy makers' timely and relevant data to assess the effectiveness of Patient Navigation and Patient Choice models of care as potentially useful re-entry and relapse prevention treatment options.
Conditions Studied
Interventions
- BEHAVIORAL Standard PN
- BEHAVIORAL Patient Choice
Study Locations (4)
Texas
- University of Texas Southwestern Medical Center (UTSW) - Dallas
- Texas Christian University's (TCU) School of Medicine - Fort Worth
Connecticut
- Yale School of Medicine - New Haven
Kentucky
- College of Medicine at the University of Kentucky - Lexington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2025-11-24 |
| Est. Completion | 2028-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07223398
The ClinicalTrials.gov registry entry for NCT07223398 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 496-participant average among 93 other Substance Use Disorders trials with a reported enrollment target (19% lower). The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Substance Use Disorders appearing as the primary indexed condition, and to 2 interventions - of which Standard PN is the first listed.
NCT07223398 reports 4 study locations spanning 3 distinct geographic areas - top geographies include Texas, Connecticut, Kentucky.
Frequently Asked Questions
What is clinical trial NCT07223398 about?
NCT07223398 is a clinical study titled "Shared Decision Making to Treat Or Prevent (STOP) HIV in Justice Populations (R33)". This study seeks to compare the effectiveness of two Patient Navigation models of care to evaluate the proportion who initiate PrEP/ART and substance use/substance use disorder (SU/SUD) treatment. A standardized Patient Navigation (PN) arm will be compared with a shared decision-making model in the ...
What is the current status of trial NCT07223398?
This trial is currently recruiting. It is a NA study. The enrollment target is 400 participants. The study started on 2025-11-24. Estimated completion is 2028-06.
What conditions does trial NCT07223398 study?
This clinical trial studies the following conditions: Substance Use Disorders.
What interventions are being tested in trial NCT07223398?
The interventions under investigation include: Standard PN (BEHAVIORAL), Patient Choice (BEHAVIORAL).
Who is sponsoring clinical trial NCT07223398?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07223398 being conducted?
This trial has 4 study locations across Connecticut, Kentucky, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Substance Use Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Supporting Treatment Access and Recovery Through Linkage and Support
RECRUITING · NA
-
Development OF A Novel Peer Recovery Supporter Training Platform
RECRUITING · NA
-
Project I Test: Implementing HIV Testing in Opioid Treatment Programs
RECRUITING · NA
-
Testing Strategies to Improve Substance Misuse Prevention Research Use in State Policy Contexts
RECRUITING · NA
-
Families Left Behind
RECRUITING · NA
-
Trauma Screening/Referral and Interpersonal Violence Prevention for Women with Substance Use Disorders
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.